Cycloset available for type 2 diabetes - ONA
Links shared publicly online about this topic.
- 723total visits
Cycloset available for type 2 diabetes - ONA
View full resource at oncologynurseadvisor.com
Tags: Diabetes, Type 2 Diabetes, Parkinson's Disease Medication, Diet and Nutrition, Exercise and Fitness, Parlodel
Most Recently Shared on November 16, 2010 at 2:59 pm By:
ACP Pressroom - American College of Physicians and Consumer Reports Announce Collaboration on New High Value Care Patient Education Resources
acponline.org — “ACP Pressroom - American College of Physicians and Consumer Reports Announce Collaboration on New High Value Care Patient Education Resources” View full resource at acponline.org
Most Recently Shared on April 19, 2012 at 7:34 pm By:
ACP & Consumer Reports collaborate http://t.co/QKME3Ltn to help patients understand appropriate treatments for common clinical issues
Free diabetes risk test available Tuesday | News-Gazette.com
news-gazette.com — “CHAMPAIGN — Type 2 diabetes often goes undetected in its early stages, but next week everyone will get a chance to assess their risk for this serious disease by taking a quick, free test.” View full resource at news-gazette.com
Most Recently Shared on March 24, 2012 at 6:20 pm By:
Free diabetes risk test available Tuesday: CHAMPAIGN — Type 2 diabetes often goes undetected in its early stages... http://t.co/kRzLfroU
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “The American College of Physicians has issued a guideline that provides three clinical recommendations regarding the comparative effectiveness and safety of type 2 diabetes medications. The guideline specifically addresses the pharmacologic management of patients with type 2 diabetes using agents from any of 11 unique classes of drugs available to treat hyperglycemia in these patients.” View full resource at aafp.org
Most Recently Shared on March 23, 2012 at 6:37 pm By:
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy http://t.co/PBkWUXwH
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “The American College of Physicians has issued a guideline that provides three clinical recommendations regarding the comparative effectiveness and safety of type 2 diabetes medications. The guideline specifically addresses the pharmacologic management of patients with type 2 diabetes using agents from any of 11 unique classes of drugs available to treat hyperglycemia in these patients.” View full resource at aafp.org
Most Recently Shared on March 23, 2012 at 6:17 pm By:
ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy: The American College of Ph... http://t.co/eccl3Dmt
Access to Health Care - American Diabetes Association
diabetes.org — “We are committed to expanding the number of people with diabetes who have insurance, and to ensuring that coverage is adequate, affordable and available.” View full resource at diabetes.org
Most Recently Shared on March 19, 2012 at 1:18 pm By:
The Affordable Care Act est. the Nat’l #Diabetes Prevention Program to prevent onset of #type2 in ppl w/prediabetes: http://t.co/W0ZqHfyB
White Rice Postulated to Increase Diabetes Risk - Physician's First Watch
firstwatch.jwatch.org — “A meta-analysis finds increased risk for type 2 diabetes with high consumption of white rice. A comment in BMJ cautions against major dietary changes, however. (A brief interview with the senior author is available through . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 17, 2012 at 8:48 am By:
Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment... -- RIDGEFIELD, Conn. and INDIANAPOLIS, March 7, 2012 /PRNewswire/ --
prnewswire.com — “Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies. JENTADUETO, available in three dosage strengths, further expands treatment options for people living with diabetes.” View full resource at prnewswire.com
Most Recently Shared on March 7, 2012 at 5:13 pm By:
Boehringer Ingelheim & Lilly's new oral type 2 diabetes treatmt, Jentadueto™, now avail in US pharmacies http://t.co/gYbPMVrL via PRNewswire
Diabetes Risk Test - American Diabetes Association
diabetes.org — “Diabetes Risk Test” View full resource at diabetes.org
Most Recently Shared on February 24, 2012 at 3:14 pm By:
@Tellab77 @AmDiabetesEOK Sure! Our #Diabetes Risk Test is available year-round & we'll have a new, improved one 3/27! http://t.co/jJC0vEya
Bydureon Available for Type 2 Diabetes - MPR
empr.com — “Bydureon (Amylin and Alkermes), a once-weekly formulation of exenatide, has been made available for the treatment of type 2 diabetes.” View full resource at empr.com
Most Recently Shared on February 13, 2012 at 7:29 pm By:
Bydureon Available for Type 2 #Diabetes http://t.co/YirkQ2H3 #endocrinology
FDA Gives Long-Awaited Nod to Amylin’s Bydureon - Diabetes Health
diabeteshealth.com — “Diabetes Health - Medications: Bydureon. After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February.” View full resource at diabeteshealth.com
Most Recently Shared on February 3, 2012 at 1:01 pm By:
FDA Gives Long-Awaited Nod to Amylin's Bydureon http://t.co/jW3wcqE4
liraglutide exenatide - TuDiabetes
tudiabetes.org — “Is anyone taking or has taken liraglutide exenatide? It's a Type 2 steroid drug similar to symlin (which is not available in Canada where I live). I've been ta…” View full resource at tudiabetes.org
Most Recently Shared on November 26, 2011 at 3:27 am By:
Type1 diabetes: liraglutide exenatide - Is anyone taking or has taken liraglutide exenatide? It's a Type 2 steroid d... http://t.co/oRakOUbb
The Pros & Cons of Insulin Therapy | Healthline
healthline.com — “Learn the benefits and pitfalls of insulin therapy, including using needles, checking blood sugar level, diet management, and more. Read on!” View full resource at healthline.com
Most Recently Shared on November 22, 2011 at 6:40 pm By:
Pros & Cons of Insulin Therapy: Decide with your doctor how your treatment can be best managed to fit your lifestyle. http://t.co/M8vJ3dKN
Juvisync Available for Type 2 Diabetes and High Cholesterol - MPR
empr.com — “Merck announced that Juvisync, a fixed-dose combination product containing the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin and the HMG-CoA reductase inhibitor simvastatin is now available.” View full resource at empr.com
Most Recently Shared on October 26, 2011 at 1:57 pm By:
Juvisync Available for Type 2 #Diabetes and High #Cholesterol http://t.co/xM44w6TT
FDA OKs diabetes, cholesterol combo drug - Related Stories - DiabetesPro SmartBrief
smartbrief.com — “Merck & Co. secured marketing approval from the FDA for Juvisync, a treatment containing the firm's type 2 diabetes pill Januvia and cholesterol-lowering statin simvastatin. The combination was approved for marketing in multiple strengths. "Dose selection should factor in what other drugs the patie…” View full resource at smartbrief.com
Most Recently Shared on October 10, 2011 at 4:03 pm By:
Available in 6 dosages RT @Eatingsoulfully: FDA OKs diabetes, cholesterol combo drug http://t.co/5Wp37M2a #diabetes
Takeda, AACE partner to launch Diabetes Navigator website
news-medical.net — “The American Association of Clinical Endocrinologists (AACE) and Takeda Pharmaceuticals North America Inc. (Takeda) have partnered to launch the Diabetes Navigator, a compendium capturing a selection of useful and reliable type 2 diabetes information available online for patients and caregivers.” View full resource at news-medical.net
Most Recently Shared on September 28, 2011 at 11:26 am By:
Takeda, AACE partner to launch Diabetes Navigator website http://t.co/ORPZ0V6j
Advertisement

